G. Forcina

发表

Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection.

G. d’Ettorre, V. Vullo, A. Corpolongo, 2000, Blood.

Interleukin-15 modulates interferon-γ and β-chemokine production in patients with HIV infection: implications for immune-based therapy

G. d’Ettorre, V. Vullo, M. Lichtner, 2004 .

Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.

G. d’Ettorre, V. Vullo, A. Corpolongo, 2001, AIDS.

Infective endocarditis in patients with human immunodeficiency virus infection.

F. D. De Rosa, S. Cicalini, G. Forcina, 2001, The Journal of infection.

Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients.

G. d’Ettorre, V. Vullo, M. Lichtner, 1999, AIDS.

Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis.

G. d’Ettorre, V. Vullo, M. Lichtner, 2000, The Journal of infectious diseases.

Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients

G. d’Ettorre, V. Vullo, M. Lichtner, 2002, AIDS.

Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?

G. d’Ettorre, V. Vullo, C. Mastroianni, 2004, Trends in immunology.

Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy.

V. Vullo, A. Corpolongo, M. Lichtner, 1998, AIDS.

Matrix Metalloproteinase-9 and Tissue Inhibitors of Matrix Metalloproteinase-1 in Plasma of Patients Co-Infected with HCV and HIV

G. d’Ettorre, V. Vullo, G. M. Liuzzi, 2002 .

Matrix Metalloproteinase-9 and Tissue Inhibitors of Matrix Metalloproteinase-1 in Plasma of Patients Co-Infected with HCV and HIV

G. d’Ettorre, V. Vullo, G. M. Liuzzi, 2002, HIV clinical trials.

Adherence and Genotypic Drug Resistance Mutations in HIV-1-Infected Patients Failing Current Antiretroviral Therapy

G. d’Ettorre, V. Vullo, M. Andreoni, 2011, Journal of chemotherapy.

Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production

G. d’Ettorre, V. Vullo, E. Nicastri, 2002, AIDS.

Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.

G. d’Ettorre, V. Vullo, M. Lichtner, 2000, Clinical immunology.

Circulating Levels of Interleukin-7 in Antiretroviral-Naïve and Highly Active Antiretroviral Therapy-Treated HIV-Infected Patients

G. d’Ettorre, V. Vullo, M. Lichtner, 2001, HIV clinical trials.

Interleukin‐15 production by monocyte‐derived dendritic cells and T cell proliferation in HIV‐infected patients with discordant response to highly active antiretroviral therapy

G. d’Ettorre, V. Vullo, M. Andreoni, 2004, Clinical and experimental immunology.

Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.

G. d’Ettorre, V. Vullo, L. Zaffiri, 2006, Acta tropica.

Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy.

G. d’Ettorre, V. Vullo, M. Lichtner, 2004, Cytokine.

Reversal of AIDS dementia after combination therapy with stavudine, lamivudine, and nelfinavir

V. Vullo, S. Dell'isola, M. Lichtner, 1999, Journal of Neurology.

Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis after initiation of potent combination antiretroviral treatment: report of two cases.

G. d’Ettorre, V. Vullo, A. Corpolongo, 2000, The Journal of infection.

Rhodococcus equi infection of monocytes/macrophages from human immunodeficiency virus (HIV)-infected patients and healthy individuals: evaluation of intracellular killing and nitric oxide production.

V. Vullo, A. Corpolongo, M. Lichtner, 1998, FEMS immunology and medical microbiology.

Rhodococcus equi infection of monocytes/macrophages from human immunodeficiency virus (HIV)-infected patients and healthy individuals: evaluation of intracellular killing and nitric oxide production

V. Vullo, A. Corpolongo, M. Lichtner, 1998 .